NCT05153694 Infectious Complications After Cystectomy: A Prospective Observational Study
| NCT ID | NCT05153694 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ludwig-Maximilians - University of Munich |
| Condition | Bladder Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-12-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.
Eligibility Criteria
Inclusion Criteria: * Disease which requires removal of the urinary bladder Exclusion Criteria: * Patient does not want to participate
Frequently Asked Questions
Who can join the NCT05153694 clinical trial?
This trial is open to participants of all sexes, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05153694 currently recruiting?
Yes, NCT05153694 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ludwig-Maximilians - University of Munich to inquire about joining.
Where is the NCT05153694 trial being conducted?
This trial is being conducted at Munich, Germany.
Who is sponsoring the NCT05153694 clinical trial?
NCT05153694 is sponsored by Ludwig-Maximilians - University of Munich. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.